Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dao Wang and Hualiang Jiang.
Dao Wang
Connection Strength
0.958
Hualiang Jiang
  1. Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial. Front Med. 2021 Oct; 15(5):704-717.
    View in: PubMed
    Score: 0.236
  2. Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs. Sci China Life Sci. 2021 02; 64(2):330-333.
    View in: PubMed
    Score: 0.224
  3. Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Sci China Life Sci. 2020 Oct; 63(10):1617-1618.
    View in: PubMed
    Score: 0.222
  4. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Sci China Life Sci. 2020 10; 63(10):1515-1521.
    View in: PubMed
    Score: 0.221
  5. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020 Sep; 41(9):1167-1177.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.